Faeth Therapeutics (FTH) Other Non-Current Liabilities (2020 - 2026)

Faeth Therapeutics (FTH) has reported Other Non-Current Liabilities for 5 consecutive years, with $1000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Liabilities changed N/A year-over-year to $1000.0; the trailing twelve-month figure through Jun 2026 stood at $1000.0 (changed N/A YoY), and the FY2023 full-year result was $67000.0, changed N/A from the prior year.
• Other Non-Current Liabilities held at $1000.0 in Q2 2026 per FTH's latest filing, from $1000.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $72000.0 in Q2 2023 and bottomed at $1000.0 in Q1 2026.
• Historically, Other Non-Current Liabilities has averaged $47125.0 across 3 years, with a median of $67000.0 in 2023.
• The widest YoY moves for Other Non-Current Liabilities: up 100.0% in 2024, down 6.94% in 2024.
• Over 3 years, Other Non-Current Liabilities stood at $67000.0 in 2023, then changed by 0.0% to $67000.0 in 2024, then tumbled by 98.51% to $1000.0 in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1000.0, $1000.0, and $67000.0 for Q2 2026, Q1 2026, and Q2 2024 respectively.